DL-AP3 is a versatile bioactive molecule with notable inhibitory activity against glucosamine-6-phosphate synthase (GFAT) from Candida albicans, demonstrating an IC50 of 10.0 nM. This compound also shows significant antimalarial effects against various strains of Plasmodium falciparum, with IC50 values ranging from 47.1 nM to 84.4 nM over a 48-hour period, as measured by flow-cytometry. In addition, it displaces bis-ANS from Plasmodium falciparum 3D7 Hsp90 produced in Escherichia coli BL21(DE3) with at least 70% activity at a concentration of 100 µM after 30 minutes, assessed via fluorescent monochromator spectrophotometry. Beyond these activities, DL-AP3 inhibits several other targets including Lamin A splicing, Human Peripheral Myelin Protein 22, and Bacillus subtilis Sfp phosphopantetheinyl transferase. It also demonstrates inhibitory effects on Cell-membrane permeable IMPase, Human Apurinic/apyrimidinic Endonuclease 1, Bloom's syndrome helicase, Histone Lysine Methyltransferase G9a, Human Flap endonuclease 1, and Marburg Virus. Furthermore, it exhibits moderate growth inhibition against a variety of human tumor cell lines including those from the breast, lung, renal, leukemia, melanoma, prostate, ovary, colon, and central nervous system..
Note: Summary generated by AI. Data source: ChEMBL 